| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.3 | 0.005 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.43 | 0.006 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |